<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Pharmacy Blog &#187; Asthma</title>
	<atom:link href="http://annpharmacy.com/blog/tag/asthma/feed" rel="self" type="application/rss+xml" />
	<link>http://annpharmacy.com/blog</link>
	<description>Health, Diseases, Drugs &#38; medications, Online canadian pharmacy</description>
	<lastBuildDate>Wed, 08 Sep 2010 08:56:22 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.1-beta1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Boxed Warning to Be Added For Asthma Drug Omalizumab</title>
		<link>http://annpharmacy.com/blog/asthma/boxed-warning-to-be-added-for-asthma-drug-omalizumab.html</link>
		<comments>http://annpharmacy.com/blog/asthma/boxed-warning-to-be-added-for-asthma-drug-omalizumab.html#comments</comments>
		<pubDate>Thu, 08 Jul 2010 11:36:59 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Asthma]]></category>
		<category><![CDATA[Drug Omalizumab]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=393</guid>
		<description><![CDATA[Genentech has been instructed to add a boxed warning to its product label for omalizumab (Xolair), which is used to treat patients with asthma related to allergies.
The warning emphasizes that this medication may cause anaphylaxis. The FDA has also asked Genentech to revise the label and provide a medication guide for patients to strengthen the [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/boxed-warning-to-be-added-for-asthma-drug-omalizumab.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Reports About Singulair Medication</title>
		<link>http://annpharmacy.com/blog/asthma/fda-reports-about-singulair-medication.html</link>
		<comments>http://annpharmacy.com/blog/asthma/fda-reports-about-singulair-medication.html#comments</comments>
		<pubDate>Tue, 15 Dec 2009 12:41:33 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Allergic]]></category>
		<category><![CDATA[Asthma]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[Montelukast]]></category>
		<category><![CDATA[Singulair]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=129</guid>
		<description><![CDATA[The US Food and Drug Administration (FDA) investigates a prescription drug Singulair (Montelukast) used in treating asthma and allergic rhinitis. It intends to reveal a potential link between the drug&#8217;s use and changes to behavior and mood, suicide, and suicidal thinking and behavior if it takes place. According to the announcement made on 27th of [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/fda-reports-about-singulair-medication.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Singulair(R) Is also Indicated For Perennial Allergic Rhinitis</title>
		<link>http://annpharmacy.com/blog/asthma/singulairr-is-also-indicated-for-perennial-allergic-rhinitis.html</link>
		<comments>http://annpharmacy.com/blog/asthma/singulairr-is-also-indicated-for-perennial-allergic-rhinitis.html#comments</comments>
		<pubDate>Fri, 04 Dec 2009 10:32:03 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Allergic]]></category>
		<category><![CDATA[Asthma]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[Montelukast]]></category>
		<category><![CDATA[SAR]]></category>
		<category><![CDATA[Singulair]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=125</guid>
		<description><![CDATA[It has been proven that taking Singulair tablets once a day help relieve a variety of indoor and  outdoor allergy symptoms for up to 24 hours.
Gailen Marshall Jr., M.D., Ph.D., director of the  Division of Clinical Immunology and Allergy at the University of Mississippi  Medical Center in Jackson, MS,  considers allergic [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/singulairr-is-also-indicated-for-perennial-allergic-rhinitis.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Formulation Of Zyrtec Medication For Young Patients</title>
		<link>http://annpharmacy.com/blog/anti-allergic/new-formulation-of-zyrtec-medication-for-young-patients.html</link>
		<comments>http://annpharmacy.com/blog/anti-allergic/new-formulation-of-zyrtec-medication-for-young-patients.html#comments</comments>
		<pubDate>Sun, 29 Nov 2009 14:18:15 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Allergic]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[allergy medicine]]></category>
		<category><![CDATA[Asthma]]></category>
		<category><![CDATA[cetirizine]]></category>
		<category><![CDATA[Zyrtec]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=147</guid>
		<description><![CDATA[Today it has been known that New   York (USA)  Pfizer Inc and UCB Pharma confirmed a new chewable formulation of Zyrtec drug (cetirizine HCl).
Cetirizine allergy medication is considered to be the  number-one prescribed antihistamine by pediatricians and allergists for the  treatment of seasonal and perennial allergic  rhinitis (inflammation of [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/anti-allergic/new-formulation-of-zyrtec-medication-for-young-patients.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Study Of Generic Singulair</title>
		<link>http://annpharmacy.com/blog/asthma/new-study-of-generic-singulair.html</link>
		<comments>http://annpharmacy.com/blog/asthma/new-study-of-generic-singulair.html#comments</comments>
		<pubDate>Wed, 25 Nov 2009 09:22:43 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Asthma]]></category>
		<category><![CDATA[Montelukast]]></category>
		<category><![CDATA[Singulair]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=121</guid>
		<description><![CDATA[New data based on Food and Drug Administration investigation into Singulair (Montelukast) don’t confirm a link between this kind of asthma medicine and suicide. This statement is released by Leadership from the American Academy of Allergy Asthma &#38; Immunology and the American College of Allergy, Asthma &#38; Immunology. Besides FDA is confident in lacking of [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/new-study-of-generic-singulair.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
